There is no single LDL number that triggers a prescription for everyone. The clearest threshold is 190 mg/dL: at that level, guidelines recommend starting high-intensity statin therapy regardless of any other risk factors. Below 190, the decision depends on your overall cardiovascular risk profile, including whether you have diabetes, existing heart disease, or other factors that raise your chances of a heart attack or stroke.
LDL of 190 or Higher: Medication Without Question
An LDL cholesterol level of 190 mg/dL or above is classified as severe hypercholesterolemia. At this level, the American College of Cardiology and American Heart Association recommend starting a high-intensity statin without even calculating your 10-year heart disease risk. The lifetime risk is considered high enough on its own. People with LDL this elevated often have a genetic component, sometimes familial hypercholesterolemia, though the treatment recommendation applies whether or not a genetic mutation is identified.
LDL Between 70 and 189: Your Risk Score Matters
For the large number of people whose LDL falls between 70 and 189 mg/dL, the decision revolves around your estimated 10-year risk of a cardiovascular event like a heart attack or stroke. Doctors calculate this using tools that factor in your age, sex, blood pressure, cholesterol numbers, smoking status, and whether you have diabetes. The result is a percentage that places you in one of four categories:
- Low risk (under 5%): Medication is generally not recommended unless your LDL is between 160 and 189, in which case a moderate-intensity statin may be reasonable, particularly if your estimated 30-year risk is 10% or higher.
- Borderline risk (5% to under 7.5%): A statin may be considered, especially if other factors tip the scale.
- Intermediate risk (7.5% to under 20%): At least a moderate-intensity statin is recommended. For people at the higher end of this range, a high-intensity statin that lowers LDL by 50% or more is beneficial.
- High risk (20% or above): High-intensity statin therapy is strongly recommended.
This means two people with the same LDL of 140 could get different recommendations. A 45-year-old nonsmoker with normal blood pressure might not need medication yet, while a 60-year-old smoker with high blood pressure almost certainly would.
If You Have Diabetes
Diabetes changes the equation significantly. The American Diabetes Association recommends that nearly all people with diabetes between ages 40 and 75 start at least a moderate-intensity statin, regardless of their LDL level. If you have one or more additional risk factors (high blood pressure, smoking, kidney disease, family history), guidelines call for high-intensity statin therapy with a target LDL below 70 mg/dL.
For adults with diabetes between ages 20 and 39, statin therapy may be reasonable if additional cardiovascular risk factors are present. The threshold is lower and the recommendation stronger than for people without diabetes, because diabetes itself accelerates the buildup of plaque in arteries.
If You Already Have Heart Disease
For anyone with established atherosclerotic cardiovascular disease, meaning you’ve had a heart attack, stroke, or have known blockages, the approach is aggressive. High-intensity statin therapy is recommended regardless of your starting LDL. The U.S. target is an LDL below 70 mg/dL. If your LDL stays at or above 70 despite maximum statin therapy, adding a second cholesterol-lowering medication is recommended.
European guidelines push even further: the European Society of Cardiology targets an LDL below 55 mg/dL for very high-risk patients. For people who have had multiple cardiovascular events within two years despite optimal treatment, the goal drops to below 40 mg/dL. These targets often require combination therapy.
When Extra Testing Helps Decide
If you fall in a gray area where your risk score doesn’t clearly point toward or away from medication, two additional tests can help clarify the picture.
A coronary artery calcium (CAC) scan measures calcified plaque in your heart’s arteries. A score above 100, or at or above the 75th percentile for your age and sex, strongly favors starting a statin because it signals plaque buildup that standard blood tests can’t detect. A score of zero, on the other hand, suggests very low near-term risk and may justify holding off on medication. The 2025 European guideline update reinforced the value of calcium scoring and imaging for people at moderate risk or near a treatment decision threshold.
Lipoprotein(a), a genetically determined particle related to LDL, is another risk modifier. Levels above 50 mg/dL, which affect roughly one in five people, can bump you into a higher risk category and tip the decision toward treatment. This is worth measuring at least once since it doesn’t change much over your lifetime.
What Happens Before You Start Medication
Unless your LDL is 190 or higher or you have established heart disease, most clinicians will first recommend lifestyle changes: improving your diet, increasing physical activity, losing weight if needed, and quitting smoking. The typical trial period is three to six months before rechecking your numbers. If your LDL hasn’t dropped enough to change your risk category, that’s usually when medication enters the conversation.
For people whose LDL is extremely elevated or whose risk is high, lifestyle changes and medication are started at the same time rather than sequentially. Diet and exercise still matter even after starting a statin because they address risk factors that medication alone doesn’t fully cover.
Beyond Statins: When a Second Drug Is Added
Statins are the first-line treatment in virtually every scenario, but some people need additional medication. If you’re on the maximum statin dose you can tolerate and your LDL remains above target, the next step is typically ezetimibe, a pill that blocks cholesterol absorption in the gut. If LDL is still not at goal after adding ezetimibe, injectable medications called PCSK9 inhibitors can lower LDL dramatically.
Under ACC criteria, PCSK9 inhibitors are considered when LDL remains at or above 100 mg/dL on combined statin and ezetimibe therapy with less than a 50% reduction from baseline. For people with diabetes or a recent cardiovascular event, the threshold drops to 70 mg/dL. European guidelines set the bar at 140 mg/dL on combination therapy for most patients, or 100 mg/dL when disease is progressing rapidly.
The Numbers at a Glance
- 190 mg/dL or higher: High-intensity statin recommended for everyone, no risk calculation needed.
- 160 to 189 mg/dL: Statin reasonable even at low risk, especially with elevated long-term risk.
- 70 to 159 mg/dL: Decision driven by your 10-year cardiovascular risk score, diabetes status, and risk-enhancing factors.
- Below 70 mg/dL: Target goal for people with existing heart disease; below 55 under European guidelines.
Your LDL number is the starting point, but the full picture includes your age, other health conditions, family history, and sometimes imaging results. If your LDL is in the middle range and you’re unsure whether you need medication, asking your doctor to calculate your 10-year risk score is the most useful next step.